Back to search

Sweden· SE-20221221000165

Lurasidone Orifarm 37 mg Filmdragerad tablett

A lurasidone product containing lurasidone, registered in Sweden by Orifarm Healthcare A/S. The same ATC class is registered in 16 of our 19 countries.

ATC N05AE05

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedLurasidone Orifarm 37 mg Filmdragerad…ATCN05AE05REGISTER NO.SE-20221221000165PACKS LISTED1CHECKEDOctober 1, 2026

Where it is registered

Lurasidone is registered in 16 of 19 countries.

Countries holding a registration under ATC N05AE05 (lurasidone), each read from that country’s own register.

  • This record: Sweden, from Swedish Medical Products Agency (Sweden)
  • 9 of them publish a price we can compare per daily dose

Lurasidone · ATC N05AE05

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lurasidone costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $2.63 in Italy to $6.45 in Switzerland — a ×2.4 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Lurasidone · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$6.45
  • IT Italy$2.63
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Lurasidone
Manufacturer
Orifarm Healthcare A/S
Country
Sweden (SE)
ATC code
N05AE05
ATC class
Lurasidone
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20221221000165

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

242 interactions on record for lurasidone.

Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lurasidone · interactions on record

242 records

  • 32 severe
  • 205 moderate

Most severe, free to view

  • MetoclopramideA03FA01severe
  • AprepitantA04AD12severe
  • KetoconazoleH02CA03severe
  • ErythromycinJ01FA01severe

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lurasidone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lurasidone products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Lurasidon G.L., Lurasidon Genericon
  • Bulgaria · Lurasidone Accord, Луразидон Тева
  • Czechia · Isaq, Lurasidon G.L. Pharma
  • Germany · Lurasidon Elpen
  • Denmark · Elgera, Lurasidone Accord
  • Spain · Lurasidona Cinfa, Lurasidona Tecnigen
  • Finland · Lurasidone Accord
  • United Kingdom (Northern Ireland) · Lurasidone Accord Healthcare, Lurasidone Amarox
  • Greece · Elgera, Latomno
  • Croatia · Lurasidon Teva
  • Iceland · Latuda
  • Italy · Lurasidone Accord, Lurasidone Doc
  • Liechtenstein · Latuda
  • Netherlands · Lurasidon Teva
  • Norway · Latuda, Lurasidone Accord
  • Poland · Alurazen, Asil
  • Portugal · Latomno, Lurasidona Farmoz
  • Slovenia · Lurasidon Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e9ca9e46-60eb-400a-ad44-9e8e236a850c
GET /v1/drugs/e9ca9e46-60eb-400a-ad44-9e8e236a850c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL",
    "SmPC"
  ],
  "se_npl_id": "20221221000165",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20221221000165",
  "product_doc_link": "https://docetp.mpa.se/LMF/Lurasidone%20Orifarm%20film-coated%20tablet%20SmPC_09001bee83fd595d.pdf"
}

See everything about lurasidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.